Us Physicalrapy Stock Performance
| USPH Stock | USD 74.00 0.95 1.27% |
On a scale of 0 to 100, US Physicalrapy holds a performance score of 8. The entity owns a Beta (Systematic Risk) of 1.29, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, US Physicalrapy will likely underperform. Please check US Physicalrapy's coefficient of variation, semi variance, period momentum indicator, as well as the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether US Physicalrapy's current price history will revert.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in US Physicalrapy are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady basic indicators, US Physicalrapy demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (1.27) | Five Day Return (0.05) | Year To Date Return (15.79) | Ten Year Return 39.05 | All Time Return 3.8 K |
Forward Dividend Yield 0.023 | Payout Ratio | Last Split Factor 3:2 | Forward Dividend Rate 1.8 | Dividend Date 2025-06-13 |
1 | U.S. Physical Therapy Announces the Acquisition of an Outpatient Home Care Physical and Speech Therapy Practice | 04/30/2025 |
2 | Is the Options Market Predicting a Spike in U.S. Physical Therapy Stock | 05/13/2025 |
3 | Acquisition by Kathleen Gilmartin of 1882 shares of US Physicalrapy subject to Rule 16b-3 | 05/20/2025 |
4 | Disposition of 633 shares by Eric Williams of US Physicalrapy at 78.09 subject to Rule 16b-3 | 05/21/2025 |
| US Physicalrapy dividend paid on 23rd of May 2025 | 05/23/2025 |
5 | U.S. Physical Therapy Initiates Dual Listing on NYSE Texas USPH Stock News | 05/28/2025 |
6 | Disposition of 10000 shares by Christopher Reading of US Physicalrapy at 90.01 subject to Rule 16b-3 | 06/04/2025 |
7 | ELAN vs. USPH Which Stock Should Value Investors Buy Now | 06/10/2025 |
8 | USPH Q1 Earnings Call Management Highlights Volume Growth and Contracting Initiatives Amid Medicare Headwinds | 06/11/2025 |
9 | US Physical Therapy Inc Highlights Participation in Key Healthcare Conferences USPH ... | 06/12/2025 |
| US Physicalrapy dividend paid on 13th of June 2025 | 06/13/2025 |
10 | USPH to Participate in Barrington Event in Denver and Portland USPH Stock News | 06/16/2025 |
11 | EULAV Asset Management Sells 6,600 Shares of U.S. Physical Therapy, Inc. | 07/07/2025 |
12 | Schechter Investment Advisors LLC Has 967,000 Stock Position in U.S. Physical Therapy, Inc. | 07/15/2025 |
| Begin Period Cash Flow | 152.8 M | |
| Total Cashflows From Investing Activities | -149.4 M |
US Physicalrapy Relative Risk vs. Return Landscape
If you would invest 6,591 in US Physicalrapy on April 20, 2025 and sell it today you would earn a total of 809.00 from holding US Physicalrapy or generate 12.27% return on investment over 90 days. US Physicalrapy is currently generating 0.2023% in daily expected returns and assumes 1.7711% risk (volatility on return distribution) over the 90 days horizon. In different words, 15% of stocks are less volatile than USPH, and 96% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
US Physicalrapy Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for US Physicalrapy's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as US Physicalrapy, and traders can use it to determine the average amount a US Physicalrapy's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1142
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | USPH | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.77 actual daily | 15 85% of assets are more volatile |
Expected Return
| 0.2 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average US Physicalrapy is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of US Physicalrapy by adding it to a well-diversified portfolio.
US Physicalrapy Fundamentals Growth
USPH Stock prices reflect investors' perceptions of the future prospects and financial health of US Physicalrapy, and US Physicalrapy fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on USPH Stock performance.
| Return On Equity | 0.0663 | ||||
| Return On Asset | 0.0402 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 1.41 B | ||||
| Shares Outstanding | 15.19 M | ||||
| Price To Earning | 34.35 X | ||||
| Price To Book | 2.29 X | ||||
| Price To Sales | 1.62 X | ||||
| Revenue | 560.55 M | ||||
| Gross Profit | 150.56 M | ||||
| EBITDA | 86.91 M | ||||
| Net Income | 45.6 M | ||||
| Cash And Equivalents | 48.57 M | ||||
| Cash Per Share | 3.73 X | ||||
| Total Debt | 295.23 M | ||||
| Debt To Equity | 0.57 % | ||||
| Current Ratio | 1.43 X | ||||
| Book Value Per Share | 32.73 X | ||||
| Cash Flow From Operations | 74.94 M | ||||
| Earnings Per Share | 2.18 X | ||||
| Market Capitalization | 1.12 B | ||||
| Total Asset | 1.17 B | ||||
| Retained Earnings | 227.26 M | ||||
| Working Capital | 21.3 M | ||||
| Current Asset | 60.18 M | ||||
| Current Liabilities | 19.01 M | ||||
About US Physicalrapy Performance
By evaluating US Physicalrapy's fundamental ratios, stakeholders can gain valuable insights into US Physicalrapy's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if US Physicalrapy has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if US Physicalrapy has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | (2.13) | (2.23) | |
| Return On Tangible Assets | 0.08 | 0.12 | |
| Return On Capital Employed | 0.06 | 0.06 | |
| Return On Assets | 0.02 | 0.02 | |
| Return On Equity | 0.05 | 0.08 |
Things to note about US Physicalrapy performance evaluation
Checking the ongoing alerts about US Physicalrapy for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for US Physicalrapy help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Over 98.0% of the company outstanding shares are owned by institutional investors | |
| On 13th of June 2025 US Physicalrapy paid $ 0.45 per share dividend to its current shareholders | |
| Latest headline from thelincolnianonline.com: Schechter Investment Advisors LLC Has 967,000 Stock Position in U.S. Physical Therapy, Inc. |
- Analyzing US Physicalrapy's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether US Physicalrapy's stock is overvalued or undervalued compared to its peers.
- Examining US Physicalrapy's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating US Physicalrapy's management team can have a significant impact on its success or failure. Reviewing the track record and experience of US Physicalrapy's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of US Physicalrapy's stock. These opinions can provide insight into US Physicalrapy's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for USPH Stock analysis
When running US Physicalrapy's price analysis, check to measure US Physicalrapy's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy US Physicalrapy is operating at the current time. Most of US Physicalrapy's value examination focuses on studying past and present price action to predict the probability of US Physicalrapy's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move US Physicalrapy's price. Additionally, you may evaluate how the addition of US Physicalrapy to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |